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Abstract In industrialized countries, a large part of the
population is daily exposed to low K+ intake, a situation
correlated with the development of salt-sensitive hyper-
tension. Among many processes, adaptation to K+-restric-
tion involves the stimulation of H,K-ATPase type 2
(HKA2) in the kidney and colon and, in this study, we
have investigated whether HKA2 also contributes to the
determination of blood pressure (BP). By using wild-type
(WT) and HKA2-null mice (HKA2 KO), we showed that
after 4 days of K+ restriction, WT remain normokalemic
and normotensive (112 ± 3 mmHg) whereas HKA2 KO
m i c e e x h i b i t h y p o k a l em i a a n d h y p o t e n s i o n
(104 ± 2 mmHg). The decrease of BP in HKA2 KO is
due to the absence of NaCl-cotransporter (NCC) stimula-
tion, leading to renal loss of salt and decreased extracel-
lular volume (by 20 %). These effects are likely related to
the renal resistance to vasopressin observed in HKA2 KO
that may be explained, in part by the increased production
of prostaglandin E2 (PGE2). In WT, the stimulation of
NCC induced by K+-restriction is responsible for the
elevation in BP when salt intake increases, an effect
blunted in HKA2-null mice. The presence of an activated
HKA2 is therefore required to limit the decrease in plas-
ma [K+] but also contributes to the development of salt-
sensitive hypertension.
Keywords Blood pressure . Extracellular volume . Low-K+
diet . Vasopressin . Na+/Cl−-cotransporter
Introduction
Disturbances in the potassium balance are at the origin of
many complications and are potentially life-threatening. The
organism is rather well protected against hyperkalemia; how-
ever, when it occurs, its consequences (which are mainly car-
diac) are rapidly fatal. Hypokalemia is a disorder more fre-
quent than hyperkalemia. The prevalence of hospitalized pa-
tients with a plasma [K+] < 3 mM is 3–5 % [29, 30] and
reaches 12 % when the cut-off is 3.5 mM [9]. Its origins are
generally multifactorial and involve vomiting, diarrhea, di-
uretic abuse and can be linked also to genetic disorders
(Conn’s disease, Bartter and Gitelman syndrome, for in-
stance). In addition to pathological states leading to hypoka-
lemia, dietary behaviors may also contribute to lower the
whole body K+ content. In developed Western countries, con-
sumption of Na+ has increased well above physiological needs
whereas that of K+ has dramatically decreased [11]. Studies
focusing on the impact of a low daily intake of K+ in humans
have demonstrated a positive correlation with the probability
for developing hypertension by mechanisms that remain part-
ly unsettled [7, 14, 19]. Conversely, analysis of K+-depleted
animal models (normal or hypertensive) suggests that a low
K+ intake induces a decrease in blood pressure (BP) [18, 21,
28]. This discrepancy is probably not related to species
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differences in the blood pressure response to dietary K+ re-
striction but is rather due to the degree of K+ restriction, which
is moderate in human studies and almost complete in animal
studies but also to the large amount of Na+ normally ingested
by the general population compared to the experimental
models. Recent studies [3, 37, 39, 40] highlight the role of
the thiazide-sensitive Na+/Cl−-cotransporter (NCC) in the de-
velopment of a salt-sensitive hypertension induced by a low-
K+ diet. However, the molecular trigger of NCC stimulation in
this context is still debated since it could be hypokalemia [37]
or peptide hormones like vasopressin (AVP), for instance [3].
Many coordinated regulatory processes are involved in reg-
ulating the potassium balance [42]. In the case of dietary K+
restriction, the retention of K+ is favored, via the inhibition of
renal K+ secretion through the K+ channel ROMK (for review
see [41]) and the stimulation of K+ reabsorption through a
progesterone-dependent activation of the H,K-ATPase type 2
(for review see [8]). This last process has been challenged by
the lack of renal phenotype in HKA2-null mice fed a low-K+
diet [22]. More recently, however, we have discovered that
HKA2-null mice do not retain K+ correctly during gestation
[34] and exhibit circadian defects in urinary excretion of K+
that affects plasma K+ levels [33]. Moreover, when we acutely
inhibited the K+-restriction-induced stimulation of HKA2 by
blocking the nuclear progesterone receptor, the mice
displayed a higher loss of K+ in their urine and a lower plasma
K+ level [12]. These recent data showed that the renal expres-
sion of HKA2 is not an epiphenomenon and that HKA2-null
mice, as many knock-out models, may develop compensatory
systems to override the gene deletion.
Since HKA2 contributes to the regulation of the K+ balance
and modifications of the dietary K+ intake alters BP levels, we
aimed at better determining whether HKA2 helps in control-
ling BP under K+- depletion conditions.
Material and Methods
Physiological analysis
Experiments were performed on C57Bl6 wild-type (WT) and
knock-out mice for the HKA2 α subunit gene [22]. All the
animals were house kept at CEF (Centre d’Explorations
Fonctionnelles of CRC, Agreement no. A75–06-12). They
were maintained in a constant temperature and humidity in
light controlled room with a 12 h light cycle. They had free
access to food (SAFE Laboratory) and tap water. All experi-
ments were conducted in accordance with the institutional
guidelines and the recommendations for the care and use of
laboratory animals put forward by the Directive 2010/63/EU
revising Directive 86/609/EEC on the protection of animals
used for scientific purposes (project has been approved by a
user establishment’s ethics committee and the Project
Authorization: number 2289.01). To record physiological pa-
rameters, mice were placed in metabolic cages (Techniplast,
France) and were fed either a standard laboratory diet (0.28 %
Na + and 0.6 %K+; Safe France) or a low-K+ diet (0.28 %Na+
and 0.01 % K+; Safe France). Urinary creatinine concentra-
tions were determined using an automatic analyzer (Konelab
20i; Thermo, France). Urinary Na+ and K+ concentration was
determined by flame photometry (IL943, Instruments labora-
tory, France). Urinary aldosterone content was determined
using an EIA kit (USCN Life Science Inc) according to sup-
plier’s recommendation. Urine PGE2 was measured by using
an EIA method according to supplier ’s information
(Prostaglandin E metabolite EIA kit, Cayman Chemicals).
Thiazide and amiloride-sensitive natriuresis were measured
as previously described [20, 25]. To test for the vasopressin
response, dDAVP (1.5 μg/kg in 100 μl of 0.9 % NaCl) or its
vehicle were injected intraperitoneally and a spot of urine was
taken 5 h post-injection for measurement of osmolality (Vogel
6300 Voebling osmometer, Bioblock Scientific) and com-
pared to the osmolality of urine taken before injections. A
specific V2 receptor antagonist (SR121463A, from Sanofi-
Aventis, kindly provided by Nadine Bouby, Cordelier
Research Center, INSERM [32]) was mixed in the food to
provide 1.5 mg/animal. This treatment triggers a comparable
polydipsia inWTand HKA2-null mice (40–44 ml/day in both
strain). Plasma volume was determined by Evans blue dye
dilution as previously described [2, 6, 24] in anesthetized an-
imals (a mix of xylazine, 10 mg/kg and ketamine 100 mg/kg).
Blood pressure was measured in conscious restrained mice by
a tail-cuffed plethysmography method (BP2000, Visitech sys-
tem, France) after a week of adaptation to the apparatus be-
tween 9:00 and 11:00 AM.
Quantitative PCR
RNAs were extracted from whole kidneys using the TRI re-
agent (Invitrogen, France) following the manufacturer’s in-
structions. One μg of total RNA was then reverse-
transcribed (Roche Diagnostics, France) and real-time PCRs
were performed on a LightCycler (Roche Diagnostics,
France) as previously described [15].
Membrane protein extraction and western blot analysis
Total kidneys were homogenized in a lysis buffer (250 mM
sucrose, 100 mM Tris-Hepes, pH 7.4 and protease inhibitor
cocktail (Complete, Roche Diagnostics)). After removal of
aggregates and nuclear-associated membrane by low-speed
centrifugations, the plasma membrane enriched fraction
(17,000 × g for 30 min) was recovered into the lysis buffer
and its protein content was measured with the BCA method
(Thermo Scientific Pierce). Forty μg of protein were then
denaturated, resolved by SDS-PAGE (10 % polyacrylamide)
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and transferred onto a nitrocellulose membrane. Ponceau red
labeling was carried out to check for protein loading accuracy.
Western blots were performed according to the standard pro-
cedure using a polyclonal anti-total NCC antibody, an anti-
ENaC γ subunit antibody kindly provided by Jan. Loffing
(University of Zurich, [36]) or a goat-anti-AQP2 (Santa
Cruz). For quantification, the band intensities were normal-
ized by Ponceau red intensity rather than using a protein mark-
er such as β-actin, the protein expression of which is affected
by K+ restriction [5].
Immunofluorescence on kidney slice
Before or after 4 days of K+ restriction, anesthetized mice
(10 mg/kg xylazine and 100 mg/kg ketamine) were perfused
with 4 % paraformaldehyde in the aorta and the kidneys were
removed and frozen in OCT. Five μm thick slices were then
processed for immunofluorescence microscopy using an anti-
AQP2 antibody (1/200) and confocal microscopy analysis
(Leica LSM 710).
Data and statistical analysis
Results are expressed as mean ± s.e.m. The numbers of mice
used in these experiments are indicated in the legends (n). One-
way or two-way ANOVA tests as well as non-paired Student t-
test were used to determine statistical significance (see the leg-
ends), differences with p < 0.05 were considered significant.
Results
Under K+ restriction, the absence of H,K-ATPase type 2
accelerates the development of hypotension
As already observed [22, 33], the dietary K+ restriction induced
profound physiological changes (Table 1) that differ in their
kinetics between WT and HKA2-null mice, including parallel
loss of weight and food intake. HKA2-null mice have been
shown to loose K+ in their feces [22, 33, 34] thus accelerating
the development of hypokalemia that is already present after
only 4 days of K+ restriction whereas WT mice remained nor-
mokalemic (3.16 ± 0.11 vs 3.60 ± 0.09 mM, p = 0.005).
Systolic BP was measured in wild-type animals under nor-
mal K+ conditions (NK, white bars) or under dietary K+ re-
striction (LK, gray bars). It remained stable for up to 13 days
under normal condition but start decreasing significantly after
13 days of K+ restriction (p < 0.01 compared to day1 and to
day13 of NK; Fig. 1A). Comparison betweenWT (white bars)
and HKA2-null mice under normal dietary conditions (day −1
and day −2) shows no significant differences in their BP level
(Fig. 1B). After a switch to a K+ restricted diet, the HKA2-null
mice decreased their BP (at d1-d2) than in WT mice. The
difference in BP between the two genotypes reached 8–
15 mmHg up to the 6th day of K+ restriction. After that, the
difference disappeared and both genotypes reached a similar,
low BP at day 13 (around 100 mmHg).
Renal Na+ and water losses are at the origin of the K+-
depletion induced hypovolemia in HKA2-null mice
We then directly measured plasma volume by injecting a
known quantity of Evans blue dye in the circulation. These
experiments were carried-out at day 4 of the low-K+ diet,
when BP has started to decrease in HKA2-null mice but re-
mains normal in WT mice. As shown in Fig. 2A, the volume
of the plasma compartment was similar before and after the
low-K+ diet switch in WTmice (934 ± 57 μl and 929 ± 50 μl,
respectively). In contrast, in HKA2-null mice (Fig. 2B), plas-
ma volumewas 200 μl lower on the 4th day of the low-K+ diet
than before the switch (837 ± 49 μl and 1044 ± 67 μl, respec-
tively; p = 0.027). As expected, WT mice under low-K+ diet
rapidly decreased their production of aldosterone (by 70 %
compared to day-1, p < 0.01, Fig. 2C). In HKA2-null mice
the decrease of urinary aldosterone is more modest and reach
only 40 % compared to day-1 (p = 0.02 at day1). Thus, after
4 days of K+ restriction, HKA2-null mice excreted 2 times
more aldosterone than WT (p < 0.01), which may outline that
the volume depletion observed in HKA2-null mice
Bantagonized^ the effect of the K+ depletion.
A 20 % decrease in plasma volume is likely to originate
from a reduced ability of the kidney to retain Na+ and water.
Table 1 Metabolic parameters ofWT (n = 15) and HKA2-null mice (n = 16) under normal (day-1) and lowK+ diet (days 4 and 13). Results are shown
as mean ± s.e.m. HKA2-null mice vs WT, non-paired Student t-test (* p < 0.05)
K+ restriction (day) Day −1 Day 4 Day 13
WT HKA2-KO WT HKA2-KO WT HKA2-KO
Weight (g) 26.0 ± 1.0 26.3 ± 0.5 22.0 ± 1.4 22.6 ± 0.6 23.3 ± 0.9 19.0 ± 0.6*
Food intake (g) 4.3 ± 0.1 4.3 ± 0.2 3.1 ± 0.2 2.5 ± 0.2 3.7 ± 0.3 2.4 ± 0.3*
Plasma K+ value (mM) 3.95 ± 0.10 4.12 ± 0.16 3.60 ± 0.09 3.16 ± 0.11* 3.26 ± 0.16 2.80 ± 0.13*
Urine K+ μmol/24 h 515 ± 32 503 ± 27 12 ± 1 10 ± 4 12 ± 2 6 ± 1
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We therefore measured urinary water and Na+ excretion be-
fore and during a four-day period of low-K+ diet. As shown in
Fig. 2D urine volume was slightly increased (by 30 % at day4
compared to day-1, p < 0.01) inWTmice under a low-K+ diet
(white bars) during this period of 4 days and is almost doubled
after 13 days of treatment (p < 0.01). In HKA2-null mice,
urine volume increased faster than in in WT mice, with an
increase of 50 % and 90 % at day 3 and 4 compared to day-
1 (p < 0.01). Therefore, in the short period of K+ restriction,
the absence of HKA2 induced a higher loss of fluid than in
WT mice (30 % at day3, p = 0.042 and 50 % at day4,
p < 0.01). After a prolonged period of K+ restriction, WT
and HKA2-null mice displayed a similar loss of fluid.
Regarding Na+ excretion (Fig. 2E), it was normalized by the
amount of food intake so as to avoid biases stemming from the
decrease in food intake occurring in both strains after the
switch (as discussed above). In WT mice, urinary Na+ excre-
tion increased significantly but transiently in the first days
after the switch to a K+-restricted diet compared to NK diet
(64 ± 3 μmol/g, p < 0.01; 62 ± 4 μmol/g, p < 0.01 and
59 ± 4 μmol/g, p = 0.03 at day 1, 2 and 3, respectively; vs.
49 ± 3 μmol/g under normal conditions) and returned to a
normal value at day 4 (57 ± 6 μmol/g, p = 0.165) up to day
13 (50.8 ± 5.6 μmol/g, p = 0.83). In HKA2-null mice, urinary
Na+ excretion also increased significantly in response to K+
restriction compared to normal diet (p < 0.01), with a stronger
amplitude than that observed inWTmice since these mice lost
around 10–20 μmol/g each day during the short period of K+
restriction (p = 0.05 at day1, p = 0.03 at day2, p = 0.02 at day3
and 4). After a prolonged period of K+ restriction, HKA2-null
mice returned to a normal value (45.7 ± 4.3 μmol/g).
Fig. 1 Effect of dietary K+ restriction on blood pressure (BP) level. (A)
Systolic BP of wild-type (WT) mice under normal (white bars) or low-K+
diet (gray bars). Results are shown as the mean ± s.e.m. (n = 6–9). Two-
way ANOVA test was performed to analyze the influence of diet (normal
or low-K+ diets) and diet duration on blood pressure. (B) Systolic BP in
WT (white bars, n = 15–20 for period d-2 to d4 and n = 6–9 for d5 to d13)
and HKA2-null mice (black bars, n = 15–20 for period d-2 to d4 and
n = 6–8 for d5 to d13) before (d-2, d-1) and after a switch to a low-K+ diet
(d1 to d13). Results are shown as the mean ± s.e.m. Non-paired Student t-
test (** p < 0.01; *p < 0.05 and ## p < 0.01 compared to d1). Two-way
ANOVA test was performed to analyze the influence of genotype and diet
duration on BP
Fig. 2 Volume of the plasma
compartment and renal water and
Na+ excretion under low K+ diet
during K+-depletion. Plasma
volume of WT (A, n = 15) and
HKA2-null mice (B, n = 15) in
normal conditions (NK) and after
4 days of a low-K+ diet (LK). (C)
24 h urine excretion of aldosterone
inWT (white bars, n = 10–12) and
HKA2-null mice (black bars,
n = 10–12) in normal conditions
(day-1) and after a switch to a low-
K+ diet (day1 – day4). Urine
volume (D) and Na+ content
(normalized to food intake, E)
from WT (n = 10–12, white bars)
and HKA2-null mice (n = 10–12,
black bars) before (day-1) and
after a low-K+ diet (day 1-day 13).
Results are shown as the
mean ± s.e.m. Non-paired Student
t-test (** p < 0.01; * p < 0.05)
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Differential regulation of NCC and ENaC in WT
and HKA2-null mice during early K+ restriction
Measurements of total NCC protein expression confirmed that
it is increased under the low-K+ diet inWT (by 70%, p < 0.01)
but not in HKA2-null animals (Fig. 3A). Finally, the function-
al activity of NCC was assessed in vivo in both strains before
and after a 4-day period of low-K+ diet, by measuring the
acute natriuretic effect of a single dose of hydrochlorothiazide
(ip injection of HCTZ, 50 mg/kg for 6 h). As shown in
Fig. 3B, under normal-K+ conditions, HCTZ induced a similar
natriuretic response in WT and HKA2-null mice (around
100 μmol Na+/μmol of creatinine). During K+ restriction,
the natriuretic effect of HCTZ was increased by 50 % in WT
mice (compared to normal K+ condition, p < 0.01). In HKA2-
null mice, the response to HCTZ (122 μmol Na+/μmol creat-
inine) was not significantly increased compared to that under a
normal K+ diet (p = 0.097) and was much weaker than that in
WT (p < 0.01). Thus, NCC stimulation appears to be blunted
in HKA2-null mice after 4 days of K+ restriction.
The protein expression of the γ subunit of ENaC (90 kDa
band) is decreased by 25 % in WT mice after 4 days of the
low-K+ diet (p < 0.01) and is not modified in HKA2-null mice
(Fig. 3C). It has to be noted that a cleaved band at 70 kDa
should be observed when ENaC is stimulated. In our Western
Blot, this band is barely visible either in normal or low-K+
conditions indicating that ENaC is not stimulated in any con-
ditions. The functional activity of ENaC was assessed by test-
ing the natriuretic effect of an acute injection (ip) of amiloride.
As shown in Fig. 3D, the natriuretic effect of amiloride was
decreased by 30 % in WT mice under the low-K+ diet com-
pared to normal conditions (p = 0.03). In contrast, the natri-
uretic response to amiloride in HKA2-null mice was not af-
fected by the change in dietary conditions.
Vasopressin response is blunted in HKA2-null mice
at the early stage of K+ restriction
The loss of extracellular volume may also be explained by
alteration of the process controlled by vasopressin (AVP).
Fig. 3 Regulation of NCC and ENaC in WTand HKA2-null mice under
low-K+ diet. (A) Protein expression and quantification of NCC on renal
membrane preparations from WT and HKA2-null mice (HKA2 KO)
under normal (NK) or low-K+ diets for 4 days (LK). (B) Natriuretic
effects of acute (6 h) thiazide treatment performed in WT (n = 12) and
HKA2-null mice (n = 12) before (NK, white bar for WTand black bar for
HKA2 KO) and after 4 days of low-K+ diets (LK, gray bar for WT and
hatched bar for HKA2 KO). This protocol has been shown [20] to not
have any natriuretic effect on NCC-null mice indicating that with this
dose and in this time window the only transporter affected is NCC. (C)
Protein expression and quantification of ENaC γ subunit on renal
membrane preparations from WT and HKA2-null mice (HKA2 KO)
under normal (NK) or low-K+ diets for 4 days (LK). (D) Natriuretic
effects of acute (4 h) amiloride treatment performed in WT (n = 12) and
HKA2-null mice (n = 12) before (NK, white bar for WTand black bar for
HKA2 KO) and after 4 days of low-K+ diets (LK, gray bar for WT and
hatched bar for HKA2KO). Results are shown as the mean ± s.e.m. Non-
paired Student t-test (** p < 0.01; * p < 0.05)
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We tested this hypothesis by measuring the expression of
aquaporin-2 (AQP2) water channels under our different con-
ditions. As shown in Fig. 4A, AQP2 protein (the core-
glycosylated form; cg, the fully-glycosylated form; fg or both;
total) level is decreased by 30 % (p < 0.05) in WT mice after
4 days of K+ restriction. In HKA2-null mice (Fig. 4A), K+
restriction induced a more severe decreased (by 55–60 %) of
the expression of AQP2 (cg, fg and total protein, p < 0.01).
Noteworthy, under normal condition, although total AQP2
level is similar between WT and HKA2-null mice, the repar-
tition between cg and fg is different. Thus, HKA2-null mice
display a higher level of cg AQP2 and a lower level of fg
AQP2, possibly indicating that HKA2-null mice have lower
level of AQP2 at the cell surface. To better investigate the
localization of AQP2, we performed immunolabeling of
AQP2 on kidney slices of WT and HKA2-null mice under
normal or low K+ diet. As shown in Fig. 4B, AQP2 displayed
a sharp labeling at the apical sides of collecting duct cells in
WT mice fed a normal chow. Potassium restriction slightly
modified this localization. In HKA2-null mice under normal
diet, the labeling was more diffuse (less sharp) but remained
localized to the apical sides indicating that AQP2 may be
stored in sub-membrane vesicles. Under low-K+ diet (LK),
the localization of AQP2 was less pronounced at the apical
side and exhibited a strong intracellular labeling in many cells
of the HKA2-null mice CD.
To investigate further this hormonal system, we measured
the acute concentrating effect of dDAVP (V2 receptor agonist)
in WT and HKA2-null mice under normal and low K+ diets.
As shown in Fig. 4C, inWTanimals, 4 days of the lowK+ diet
did not modify urine osmolality compared to the normal diet
(1412 ± 110 and 1850 ± 267 mOsmol/kg, respectively). In
both dietary conditions, injection of dDAVP induced a 2-
fold increase in urine osmolality (Fig. 4C and D), which
reached 3151 ± 199 and 3166 ± 118 mOsmol under the nor-
mal and low K+ diets, respectively. Therefore, in WT mice
under K+ restriction, the concentrating effect of dDAVP re-
mains as efficient as in normal conditions. In HKA2-null
mice, urine osmolality was similar under the normal and low
K+ diets (1994 ± 228 and 1895 ± 204 mOsmol/kg, respective-
ly). As in WT mice, there was a 2-fold increase in urine os-
molality after dDAVP injection under normal conditions
(3600 ± 169 mOsmol/kg, Fig. 4C and D). However, under
the low-K+ diet, the dDAVP-induced increase in urine osmo-
lality (2918 ± 127mOsmol/kg) was significantly lower than in
WTmice (1.5-fold vs 2.3-fold, p = 0.018 Fig. 4D). This result
Fig. 4 Modification of the renal water transport system byK+ restriction.
(A) Protein expression of AQP2 in whole kidney of WT (upper panel)
and HKA2-null mice (lower panel) and their quantification under normal
(NK, white bars for WT and black bars for HKA2-null mice) or low-K+
diets for 4 days (LK, gray bars for WT and hatched bars for HKA2-null
mice). Results are shown as themean ± s.e.m. (n = 5). Non-paired Student
t-test (** p < 0.01; * p < 0.05). (B) Cell localization of AQP2 in collecting
tubules of WT and HKA2-null mice under normal or low-K+ diet. (C)
Urine osmolality was measured before and 5 h after an acute injection of
dDAVP to WT mice under normal (white bars) or low-K+ diets (gray
bars) or to HKA2-null mice under normal (black bars) or low-K+ diets
(hatched bars). (D) Urine osmolality measured after dDAVP injection
normalized by those obtained with the same animal before the
treatment. (E) Natriuretic effects of acute (6 h) thiazide treatment after
4 days of low-K+ diets performed in WT (n = 6, gray bars) and HKA2-
null mice (n = 6, black bars) treated (hatched bars) or not (plain bars) by a
specific V2 receptor antagonist (SR121463). Results are shown as the
mean ± s.e.m. Non-paired Student t-test (* p < 0.05)
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indicates that the response to vasopressin is partially blunted
in HKA2-null mice under K+ restriction.
To investigate the putative involvement of vasopressin and
its V2 receptors in the stimulation of NCC during a short
period of low-K+ diet, we treated our mice with a specific
V2 antagonist, SR 121463 A. Under NK diet (not shown),
this antagonist did not modify the response to thiazide in
WT or HKA2-null mice compare to non-treated animals.
However, as shown in Fig. 4E, after 4 days of LK diet, the
inhibition of V2 receptors reduced the thiazide-sensitive na-
triuresis of WT mice but did not affect that of HKA2-null
mice. This result indicates that a vasopressin-dependent pro-
cess targeting the distal convoluted tubules is involved in the
natriuretic response to K+-restriction but absent in HKA2-null
mice.
HKA2-null mice produce PGE2 in response to K+
restriction
A possible explanation for both the decreased effect of vaso-
pressin and expression of AQP2 in HKA2-null mice under
low-K+ diet and their loss of salt may be a higher production
of PGE2, a known natriuretic hormone that antagonizes the
action of vasopressin [4, 16]. As shown in Fig. 5A, the mRNA
of Cox-2, the enzyme that participates at the generation of
PGE2 is increased by almost 50 % in kidney of HKA2-null
mice. Moreover, the urinary excretion of PGE2 is 2-fold in-
creased after 4 days of K+ restriction in HKA2-null mice but
not in WT mice.
HKA2-null mice are protected against salt-sensitive
hypertension induced by K+ restriction
The results above demonstrate that WT mice, in the early
stage of K+ restriction, adapt their renal Na+ transport system
by stimulating NCC expression and activity. This likely al-
lows the organism to reduce K+ secretion in the more distal
parts of the nephron by replacing an electrogenic transport
system (ENaC) by an electroneutral one (NCC) as previously
proposed [13]. Since activation of NCCmay robustly enhance
Na+ reabsorption, we then investigated how Na+ excretion
and the blood pressure of WT and HKA2-null mice are im-
pacted by an increase in Na+ intake after a Bpreconditioning^
period of K+ restriction. Table 2 summarizes some physiolog-
ical parameters showing that addition of NaCl in the drinking
bottle did not modify the differences observed between WT
and HKA2-null mice induced by K+ restriction such as lower
plasma [K+] and weight in knock-out animals compared to
WT. However, both strains exhibited similar urine volume
and urine K+ excretion. As shown in Fig. 6A, WT and
HKA2-null mice exhibit a similar Na+ intake after two days
of low-K+ preconditioning and Na+ loading. Renal Na+ ex-
cretion is increased following Na+ loading in both genotype
but it tends to increase even more in HKA2-null mice
(Fig. 6B), which may suggest a more efficient Na+ excretion.
To confirm this hypothesis, we normalized the excretion by
calculating the mean ratio of the renal excreted Na+/Na+ in-
take (Fig. 6C) and we observed that WT mice exhibit a lower
efficiency to eliminate Na+ than HKA2-null mice (70 ± 4 %
vs 83 ± 4 %, p = 0.047 at day 4) indicating that HKA2-null
mice are more prone to excrete Na+ than WT mice when
preconditioned by a period low-K+ diet. We then measured
the consequence of this difference in ability to excrete Na+ on
the blood pressure level. After two days of K+ restriction,
addition of NaCl in the drinking water (K+ restriction being
maintained), significantly raised (one-way ANOVA,
p = 0.006) BP, by roughly 15 mmHg (Fig. 6D, black circles,
141 ± 4 and 137 ± 3 mmHg, respectively) compared to day 1
and 2 (no salt supplementation, 126 ± 4 mmHg and
128 ± 3 mmHg). In other words, at the early stage of K+
Fig. 5 Urine PGE2 content in WT and HKA2-null mice during K+
restriction. (A) mRNA expression of the cyclo-oxygenase isoform 2
(Cox-2) (as a percentage of the mean value obtained either for the WT
mice under NK or the HKA2-null mice under NK) normalized to that of
rps15, in total kidney of WT mice under a normal diet (NK, white bar,
n = 9) or K+ restriction (LK, gray bar, n = 12) and of HKA2-null mice
under a normal diet (NK, black bars, n = 8) or a low-K+ diet for 4 days
(LK, hatched bars, n = 9). (B) Total urine PGE2 excretion in WT (white
dots) and HKA2-null mice (black dots) before (d-1) and after dietary K+
restriction (d1 to d4). Results are shown as mean ± s.e.m. (n = 6)
Statistical analysis was performed by a two-way ANOVA test to
measure the potential effects of genotype, time of diet and their
interaction followed by Bonferroni posttests to compare for each time
point the WT and HKA2-null mice groups (* p < 0.05)
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restriction, when plasma [K+] levels were not yet affected,
WT mice developed a salt-sensitive hypertension.
Interestingly, the same protocol conducted in HKA2-null
mice did not yield the same results. As shown previously,
we observed a decrease in the BP during the first days of
K+-restriction (Fig. 6D, day 1 and 2). This decrease was not
significantly altered by addition of NaCl in the drinking water
(Fig. 6D, one-wayANOVA, p = 0,07) at day 3 (113 ± 3mmHg)
and day 4 (112 ± 3 mmHg) of the K+ restriction period, com-
pared to day 1 and 2 (no salt supplementation, 110 ± 3 mmHg
and 108 ± 2 mmHg) or compared to the normal dietary situa-
tion (day-1, 117 ± 2 mmHg).
Finally, comparison of WT (Fig. 6D, circles) and HKA2-
null mice (Fig. 6D, squares) clearly demonstrates that the ab-
sence of HKA2 protects against the development of this salt-
sensitive hypertension. Indeed, the difference in BP between
both strains is not significant under normal conditions (day-1),
increases as previously shown (Fig. 1B) during the first days
of K+ depletion, and finally reaches almost 30 mmHg when
salt supplementation is provided during K+ restriction (day 3
and 4, black circles and squares). Statistical analysis by a two-
way ANOVA test showed that the BP depends on genotypes
(p < 0.0001), the type of diets (p < 0.01), and the interaction of
both factors (p = 0.03).
Fig. 6 Effect of increased Na+ intake during K+ restriction on blood
pressure level of WT and HKA2-null mice. (A) Na+ intake of WT and
HKA2 KO mice under low-K+ diet and challenged with a load of NaCl
(n = 6). (B) Urine Na+/creatinine excretion of WT and HKA2 KO mice
under low-K+ diet and challenged with a load of NaCl (n = 6). (C)
Calculation of the Na+ excretion efficiency (μmol excreted/μmol
ingested) the fourth day of the experiment. (D) Systolic BP was
measured in WT (circles) and HKA2-null (squares) mice submitted to a
normal diet (white symbols), a low-K+ diet (gray symbols) and a low-K+/
high Na+ diet (black symbols). Results are shown as the mean ± s.e.m.
(n = 12–15). Statistical analysis was performed by a one-way ANOVA
test for a given genotype and by a two-way ANOVA test to measure the
potential effects of genotype and diet
Table 2 Metabolic parameters of
WT and HKA2-null mice under
normal diet (NK ; n = 15 and 16,
respectively) and after 2 days
under LK diet and NaCl loading
(2 % in drinking water) following
a period of 2 days under low K+
diet only (n = 6). Results are
shown as mean ± s.e.m. HKA2-
null mice vs WT, non-paired
Student t-test (* p < 0.05)
NK LK-HNa (day 4)
WT HKA2-KO WT HKA2-KO
Weight (g) 28.0 ± 0.8 27.0 ± 0.7 25.7 ± 0.7 23.4 ± 0.8*
Food intake (g) 3.1 ± 0.2 3.4 ± 0.3 2.5 ± 0.2 2.0 ± 0.3
Plasma K+ value (mM) 4.0 ± 0.10 4.1 ± 0.2 3.4 ± 0.1 3.0 ± 0.1*
Urine volume (ml) 0.8 ± 0.1 1.1 ± 0.2 12.6 ± 2.4 13.0 ± 2.9
Urine K+ μmol/24 h 515 ± 32 503 ± 27 12 ± 1 10 ± 4
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Discussion
In animal models, the induction of hypotension by a complete
K+ restriction has been described in many studies using dif-
ferent animal species [18, 21, 28], however, in humans for
reasons discussed below reduction of K+ intake is generally
related to hypertension. In the present study, we tried to un-
derstand the mechanisms linking K+ balance and the control
of the BP. Interestingly, we show in this study that the absence
of the HKA2 affects the regulation of volemia and BP during
K+ restriction. This could be, in part, linked to unspecific
effects related to a lower body weight or to general physiolog-
ical alterations induced by the depletion of K+. However, we
rather propose that the reduction of blood volume and, conse-
quently, of blood pressure is a physiological response that
helps maintaining the plasma K+ level in the HKA2-null mice
as we will discuss below.
Short-term adaptation to K+ restriction requires
modification of the renal Na+ transport system
in wild-type animals
It is well established that a low-K+ diet induces a fall in aldo-
sterone production that results in a decrease in ENaC expres-
sion [13] and in vivo activity (this study). In addition, the
decreased Na+ transport in the thick ascending limb of K+-
depleted animal reported years ago [17] was associated by
Amlal et al. [1] to the reduced mRNA expression as well as
the low activity of NKCC2. ENaC and NKCC2 inhibition
should lead to a major loss of Na+ and fluid in the urine.
However, K+-depletedWTanimals only slightly increase their
urinary volume and Na+ excretion and therefore seem to com-
pensate these diuretic and natriuretic effects. Here, we showed
that this compensation involves an increase in the expression
and activity of NCC and requires the preservation of an effi-
cient vasopressin system. The stimulation of total NCC ex-
pression during a low-K+ diet has been reported by Palmer’s
group in rats [13] but not by Nguyen et al. [28]. Recently,
Castenada-Bueno et al. [3] as well as Wade et al. [40] ob-
served, in WT mice under the same dietary conditions as ours
(4 days of a low-K+ diet), a similar increase in total NCC
protein expression. We did not determine the level of pNCC
but the natriuretic effect of thiazide (with a protocol targeting
specifically NCC and not the pendrin/NDCBE electroneutral
transporters [20]) was clearly more important in WT mice
under a low-K+ diet, which indicates indeed increased activity
of this transporter. It is therefore likely that the stimulation of
NCC activity during a low-K+ diet helps to compensate for the
decrease in NKCC2 and ENaC expression/activity.
Interestingly, Morris et al. [26] reported that the absence of
NCC provokes a higher loss of fluid during K+ restriction,
underlying the importance of this transporter to maintain ex-
tracellular volume levels in this given condition. More
recently, Tecker et al. [37]. confirmed the role of NCC activa-
tion during K+ restriction and demonstrated that NCC-null
mice do not develop hypertension in this context.
Is vasopressin the key hormone to preserve extracellular
volume during a low-K+ diet?
Interestingly, in their study, Castaneda-Bueno et al. showed
that NCC activation under K+ restriction (WNK4-independent)
is different than that mediated by angiotensin II infusion
(WNK4-dependent). Since OSR1 (which may compensate
for the absence of SPAK under a low-K+ diet) is phosphorylat-
ed after a vasopressin infusion [31, 35], this hormone may be
the trigger for promoting water preservation and stimulation of
NCC. To support this hypothesis, we showed, in the present
study, that in the context of K+ restriction, the inhibition of the
vasopressin pathway depending on V2 receptors impedes the
stimulation of NCC. Conversely, in HKA2-null mice under K+
restriction, we showed that vasopressin was less efficient in
elevating urine osmolality and that AQP2 protein level was
more severely decreased than in WT and that V2 receptor an-
tagonism has no effect on NCC activity. All these results indi-
cate that the vasopressin system is blunted in these animals after
4 days of a low-K+ diet. Interestingly, in this context, the plas-
ma [K+] of HKA2-null mice is 20 % lower than in wild-type
animals (Table 1), leading to a clear hypokalemia and modifi-
cation of this parameter may interfer with vasopressin produc-
tion. Some reports suggest that an increase in K+ intake [10] or
in plasma [K+] [38] could stimulate the production or release of
vasopressin. Conversely, K+-depleted rats displaying hypoka-
lemia exhibit a blunted response to vasopressin injections [27].
These results indicate a relationship between the level of plas-
ma [K+] and vasopressin action. Therefore, the marked hypo-
kalemia occurring in HKA2-null mice after a short period of K+
restriction may explain the reduced effects of vasopressin. A
mechanistic reason for the blunted response to vasopressin re-
mains to be investigated in more detail, but we propose that the
increased production of PGE2, a factor that antagonizes vaso-
pressin effects in different segments [4, 16], is a possible
explanation.
Low K+ diet and salt-sensitive hypertension
A recent report suggests that a decrease of plasma [K+] could
trigger the decrease of intracellular [Cl−] and in fine result in
activation of NCC through WNK4 [37]. Our physiological
observations do not fully support this idea. Indeed, a decrease
in K+ intake that does not affect plasma [K+] (our WT mice
after 4 days of LK diet as well as in [3]) already activates NCC
and induces a salt-sensitive hypertension. It seems therefore
not necessary to reach a state of hypokalemia to activate
thiazide-sensitive Na+ transport in the DCT. We, also, de-
scribed a situation where the development of hypokalemia
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(as in the HKA2-null model) does not activate NCC. The
mechanisms that regulate NCC under K+-deficiency are there-
fore more complicated.
Numerous studies indicate that the daily consumption of K+
in westernized populations is roughly 30 % lower than that
which is recommended (4.7 g or 120 mEq) by the Food and
Nutrition Board of the Institute of Medicine of the National
Academies (http://fnic.nal.usda.gov/dietary-guidance/dri-
nutrient-reports/water-potassium-sodium-chloride-and-sulfate
). It is however likely that these whole Bhealthy^ populations
are not prone to hypokalemia. A recently published association
study [23] showed that a slight decrease in K+ excretion
(reflecting a lower K+ intake) raises blood pressure and that
this effect is dependent on Na+ excretion (also reflecting Na+
intake). In this cohort, the variations in urine K+ excretion (or
K+ intake) was moderated (mean 2.12 ± 0,60 g/day) and was
not likely to be associated with a significant modifications of
plasma [K+] although this parameter was not measured. The
groups of people with a lower K+ excretion (i.e., a lower K+
intake) were in a situation likely to correspond to our WT mice
after a short period of almost complete K+ restriction, i.e. in a
situation where their plasma [K+] is in the normal range and
their NCC is activated. This activation could explain why, in
this group, as in our WT K+-depleted mice, an increase in Na+
intake raises blood pressure. This comparison is however
limited since we abruptly and strongly modified the diet
composition of our mice and only controlled prospective
studies in human with normalized low-K+ and high-Na+ diets
intake would help confirming this hypothesis.
Importance of the HKA2 in the global response to K+
restriction
Physiological adaptation to K+ restriction requires a functional
HKA2 in both the colon and kidney [12, 22]. In the present
study, we showed that stimulation of HKA2 by delaying the
decrease of plasma [K+] also helps at maintaining the volume
of the extracellular compartment since its absence promote
both hypokalemia and hypotension.
In this particular situation, since the strongest threat is the
development of a non-manageable hypokalemia, in order to
control the decline in plasma [K+], the organism reduces its
extracellular volume to the detriment of blood pressure. This
process may be considered as a positive adaptation, as it al-
lows the organism to concentrate K+ in the extracellular com-
partment and therefore to maintain plasma [K+] in a bearable
range.
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